Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Austria Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20054
20062
20072
20091
20101
20111
20122
20134
20141
20171
20181
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Bristol-Myers Squibb5
Gruppo Italiano Malattie EMatologiche dell'Adulto2
Pfizer2
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Ariad Pharmaceuticals1
Central European Leukemia Study Group1
Medical University of Graz1
Poitiers University Hospital1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive26
Leukemia5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Myeloid3
Blast Crisis2
Bone Marrow Diseases2
Hematologic Diseases2
Myeloproliferative Disorders2
Philadelphia Chromosome2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.